Coherus BioSciences Inc.

NASDAQ: CHRS · Real-Time Price · USD
1.04
0.02 (1.96%)
At close: Aug 15, 2025, 3:59 PM
1.02
-2.39%
After-hours: Aug 15, 2025, 07:33 PM EDT

Coherus BioSciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
179.75M -130.94M 28.51M -450K -29.34M -59.29M -237.89M -217.11M -264.12M -271.4M -291.75M -278.61M -230.49M -210.24M -287.1M -231.67M -165.21M -76.28M
Depreciation & Amortization
4.64M 4.82M 5.28M 5.31M 4.66M 4.35M 3.79M 3.78M 3.87M 3.88M 3.7M 3.48M 3.38M 3.37M 3.45M 3.46M 3.26M 3.13M
Stock-Based Compensation
24.05M 25.86M 27.8M 32.22M 35.3M 38.15M 43.11M 44.04M 46.37M 50.14M 50.74M 49.96M 49.61M 47.36M 51.36M 57.79M 55.16M 52.99M
Other Working Capital
-144.36M -108.61M -86.9M -22.22M 79.28M 154.66M 136.83M 46.2M 1.18M -42.45M -40.41M -7.93M -34.25M -12.13M 13.68M 19.24M 36.9M 23.49M
Other Non-Cash Items
-293.17M 23.99M -136.56M -35.87M -37.84M -27.34M 122.86M 5.57M 31.92M 33.05M 75.45M 76.8M 50.85M 41.86M 143.05M 134.96M 137.41M 150.91M
Deferred Income Tax
n/a n/a n/a -69.56M -68.69M -69.93M -69.93M -368K -1.24M n/a n/a 127K 5.58M 5.95M 9.44M 9.26M 3.7M 3.33M
Change in Working Capital
-21.14M 76.78M 54.54M 6.37M 41.63M -38.86M -36.83M -97.81M -61.49M -71.49M -79.26M -45.25M -21.63M 18.85M 42.36M 74.22M 47.33M 7.94M
Operating Cash Flow
-105.87M 500K -20.44M -61.98M -54.27M -152.92M -174.88M -261.9M -244.69M -255.81M -241.12M -193.49M -142.69M -92.84M -37.43M 48.01M 81.66M 142.03M
Capital Expenditures
n/a n/a n/a -34K -34K -134K -286K -339K -796K -1.58M -2.04M -2.42M -2.22M -1.76M -1.29M -1.76M -3.62M -5.58M
Cash Acquisitions
-12.5M 215.32M 215.32M 227.82M 227.97M 591K 769K 769K 618K 178K n/a 468K 729K 729K 729K 261K n/a n/a
Purchase of Investments
-20.73M n/a n/a n/a n/a -19.51M -19.68M -147.07M -147.07M -127.56M -127.38M -10.71M -42.16M -42.16M -182.49M -171.78M -182.31M -414.18M
Sales Maturities Of Investments
n/a 227.82M 242.71M 278.92M 322.32M 155.03M 157.64M 121.43M 78.03M 17.5M n/a 118.66M 166.36M 166.36M 166.36M 258.7M 274M 274M
Other Investing Acitivies
478.28M -433.07M -227.71M -240.65M -234.09M 235.36M 47.66M 46.21M 38.76M -3.59M -38.77M -36.8M -36.61M -11.73M -121.73M 89.75M 87.51M 58.51M
Investing Cash Flow
445.05M 10.07M 230.32M 266.07M 316.17M 329.88M 144.64M -20.46M -71.46M -113.71M -166.85M 70.54M 86.98M 111.45M -138.41M -35.84M -35.43M -298.26M
Debt Repayment
-46.41M n/a n/a -186.91M -186.77M n/a n/a n/a 49.49M 49.49M 49.93M 49.93M 440K 440K n/a n/a -674K 222.16M
Common Stock Repurchased
-264K -264K n/a n/a n/a n/a n/a n/a -321K -963K -3.62M -3.64M -3.32M -2.68M -1.75M -1.73M -1.73M -1.73M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-235.24M -186.34M -186.96M 614K 298K 514K -1.9M -2.35M -2.32M -2.38M 1.02M 2.29M 3.69M 49.83M 51.9M 55.91M 59.57M 306K
Financial Cash Flow
-281.72M -188.13M -186.97M -186.84M -175.57M 66.68M 69.6M 75.83M 113.59M 59.98M 54.33M 49.22M 1.45M 47.59M 51.88M 55.91M 58.89M 222.46M
Net Cash Flow
57.65M -177.36M 23.1M 16.98M 85.88M 243.19M 38.9M -206.53M -202.56M -309.54M -353.65M -73.73M -54.25M 66.19M -123.96M 68.08M 105.12M 66.24M
Free Cash Flow
-105.87M 500K -20.44M -62.02M -54.3M -153.05M -175.17M -262.24M -245.49M -257.39M -243.16M -195.91M -144.92M -94.6M -38.72M 46.25M 78.04M 136.45M